Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Erlotinib | 10 | uM | 9 | 1250.00 | 684.27 | 1294.00 | 1739.25 | 0.7440 | 0.6055 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 1250.00 | 684.27 | 1727.00 | 1739.25 | 0.9930 | 0.9895 |
| BT-20 | 17-AAG | 0.0031623 | uM | 9 | 1250.00 | 684.27 | 1897.00 | 1739.25 | 1.0907 | 1.1333 |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 1250.00 | 684.27 | 2198.00 | 1739.25 | 1.2638 | 1.3800 |
| BT-20 | Linsitinib | 0.01 | uM | 9 | 1250.00 | 684.27 | 1964.00 | 1739.25 | 1.1292 | 1.1890 |
| BT-20 | 17-AAG | 0.0001 | uM | 9 | 1250.00 | 684.27 | 2395.00 | 1739.25 | 1.3770 | 1.5367 |
| BT-20 | 17-AAG | 0.01 | uM | 9 | 1250.00 | 684.27 | 1133.00 | 1739.25 | 0.6514 | 0.4545 |
| BT-20 | Linsitinib | 10 | uM | 9 | 1250.00 | 684.27 | 1552.00 | 1739.25 | 0.8923 | 0.8377 |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 2240.00 | 1739.25 | 1.2879 | 1.4137 | |
| BT-20 | Lapatinib | 1 | uM | 9 | 1250.00 | 684.27 | 1866.00 | 1739.25 | 1.0729 | 1.1073 |
| BT-20 | Lapatinib | 10 | uM | 9 | 1250.00 | 684.27 | 643.00 | 1739.25 | 0.3697 | -0.0452 |
| BT-20 | Lapatinib | 0.0033113 | uM | 9 | 1250.00 | 684.27 | 2011.00 | 1739.25 | 1.1562 | 1.2278 |
| BT-20 | Linsitinib | 0.1 | uM | 9 | 1250.00 | 684.27 | 2144.00 | 1739.25 | 1.2327 | 1.3364 |
| BT-20 | Lapatinib | 0.031623 | uM | 9 | 1250.00 | 684.27 | 1968.00 | 1739.25 | 1.1315 | 1.1923 |
| BT-20 | 17-AAG | 0.031623 | uM | 9 | 1250.00 | 684.27 | 573.00 | 1739.25 | 0.3295 | -0.1235 |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 1549.00 | 1739.25 | 0.8906 | 0.8351 | |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 4265.00 | 4319.25 | 0.9874 | 0.9842 | |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 4520.00 | 4319.25 | 1.0465 | 1.0580 | |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 2500.00 | 1434.95 | 3934.00 | 4319.25 | 0.9108 | 0.8859 |
| BT-20 | 17-AAG | 0.001 | uM | 9 | 2500.00 | 1434.95 | 4172.00 | 4319.25 | 0.9659 | 0.9568 |
| BT-20 | 17-AAG | 0.000066069 | uM | 9 | 2500.00 | 1434.95 | 4441.00 | 4319.25 | 1.0282 | 1.0353 |
| BT-20 | Linsitinib | 3.1623 | uM | 9 | 2500.00 | 1434.95 | 3842.00 | 4319.25 | 0.8895 | 0.8580 |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 2500.00 | 1434.95 | 2399.00 | 4319.25 | 0.5554 | 0.3816 |
| BT-20 | Lapatinib | 0.1 | uM | 9 | 2500.00 | 1434.95 | 4555.00 | 4319.25 | 1.0546 | 1.0680 |
| BT-20 | Lapatinib | 0.0016596 | uM | 9 | 2500.00 | 1434.95 | 4527.00 | 4319.25 | 1.0481 | 1.0600 |